secwatch / observer

Calisa Acquisition Corp — fact timeline

Source-grounded facts extracted from Calisa Acquisition Corp's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.

ALIS Calisa Acquisition Corp JSON
Equity Issuances

Calisa Acquisition Corp issued 100,000 Class A ordinary shares of common stock to accredited investor for $10.00 per share.

“On April 30, 2026, in furtherance of the transactions contemplated by the BCA, the Company and Goodvision entered into a subscription agreement (“ Subscription Agreement ”) with an accredited investor (the “ Investor ”), pursuant to which the Company will, immediately prior to, and contingent upon, the consummation of the Merger, issue 100,000 Class A ordinary shares to the Investor at a price of $10.00 per share, for aggregate gross proceeds to the Company of $1 million.”
Listing & Compliance Notices

Calisa Acquisition Corp received a nasdaq deficiency notice notice regarding other (rules 5450(a)(2)).

“April 30, 2026, Calisa Acquisition Corp (the “ Company ”) received a written notice (the “ Notice ”) from the Listing Qualifications Department of The Nasdaq Stock Market (“ Nasdaq ”) indicating that the Company is not i”
Material Agreements

Calisa Acquisition Corp entered into Business Combination Agreement with Goodvision AI Inc. valued at Calisa Acquisition Corp (SPAC) will acquire Goodvision AI Inc. via merger; Goodvision shareholders r (effective 2026-03-06).

“On March 6, 2026 (the “ Execution Date ”), Calisa Acquisition Corp, a Cayman Islands exempted company (the “ Company ”), entered into an Business Combination Agreement (the “ BCA ”) with Calisa Merger Sub, a Cayman Islands exempted company and a direct, wholly owned subsidiary of the Company (“ Merger Sub ”), and Goodvision AI Inc., a Cayman Islands exempted company (“ Goodvision ”).”

Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.